CD4 and Alzheimer disease: As part of a multi-country review of AD from 2004–2015, CD4 results (baseline or otherwise) were noted in 53% of ART patient records across Zimbabwe, though it is fair to assume that this figure has declined over the past several years for the aforementioned reasons [12].